CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

PIVKA-II as a surrogate marker for prognosis in patients with localized hepatocellular carcinoma receiving stereotactic body radiotherapy

Ick Joon Cho, Jae-Uk Jeong, Taek-Keun Nam, Young-Eun Joo, Sung-Bum Cho, Yong-Hyub Kim, Ju-Young Song, Mee Sun Yoon, Sung-Ja Ahn, Woong-Ki Chung

Radiation Oncology Journal. 2022;40(1):20-28. Published online 2022 March 25 DOI: https://doi.org/10.3857/roj.2021.00934

PIVKA-II as a surrogate marker for prognosis in patients with localized hepatocellular carcinoma receiving stereotactic body radiotherapy

Ick Joon Cho, Jae-Uk Jeong, Taek-Keun Nam, Young-Eun Joo, Sung-Bum Cho, Yong-Hyub Kim, Ju-Young Song, Mee Sun Yoon, Sung-Ja Ahn, Woong-Ki Chung

Radiation Oncology Journal. 2022;40(1):20-28

Link1

Link2 Link3

PO-1066: Clinical results of stereotactic body radiotherapy for elderly hepatocellular carcinoma patients

J.Y. Jang, J. Jung, J. Park, J.H. Kim, S.M. Yoon

Radiotherapy and Oncology. 2020;152:S566

Link1 Link2

Stereotactic radiotherapy for hepatocellular carcinoma induced by hepatitis C and the relationships of changes in carbohydrate antigen 19-9 with AFP and PIVKA-II

T. Maebayashi, N. Ishibashi, T. Aizawa, M. Sakaguchi, M. Okada

Cancer/Radiothérapie. 2021;25(3):242-248

Link1 Link2

PV-0105: Stereotactic body radiotherapy treatment for hepatocellular carcinoma: A phase II study

J. Durand-Labrunie, H. Jarraya, E. Boleslawski, S. Cattan, T. Lacornerie, D. Peiffert, X. Mirabel

Radiotherapy and Oncology. 2018;127:S57

Link1 Link2

STEREOTACTIC BODY RADIOTHERAPY AND HYPOFRACTIONATED RADIOTHERAPY FOR HEPATOCELLULAR CARCINOMA: SHORT-TERM OUTCOMES AND LIVER TOLERANCE

T. McDonald, M. Fuss

Radiotherapy and Oncology. 2009;92:S144

Link1 Link2

Stereotactic body radiotherapy for patients with hepatocellular carcinoma and intermediate grade cirrhosis – Authors' reply

Alessandro Granito, Luigi Bolondi

The Lancet Oncology. 2017;18(4):e193

Link1 Link2

Clinical effects and prognosis of stereotactic body radiotherapy combined with transarterial chemoembolization for massive hepatocellular carcinoma

Jun Pang, Guang‐yuan Hao, Yan Chen

Precision Radiation Oncology. 2021;5(1):12-17

Link1 Link2 Link3

Basics of Ablative Radiotherapy: The Background Knowledge Necessary to Practicing Stereotactic Body Radiotherapy for Hepatocellular Carcinoma

Alejandra Méndez Romero, Steven Habraken, Dave Sprengers

Radiotherapy of Liver Cancer. 2021;93-106

Link1

Stereotactic Body Radiotherapy Versus Intensity-Modulated Radiotherapy For Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis

Liqing Li, Ying Zhou, Yong Huang, Ping Liang, Shixiong Liang, Tingshi Su

. 2021;

Link1 Link2

Treatment Outcomes of Hepatocellular Carcinoma Patients who underwent Stereotactic Body Radiotherapy

Paytai Rordlamool, Kittipitch Bannangkoon, Naichaya Chamroonkul

Journal of Health Science and Medical Research. 2022;

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Radiat Oncol J has participated in CrossRef Text and Data Mining service since October 29, 2014.